Latest News and Press Releases

ICP-488 is expected to provide a novel therapeutic option for patients. There are no approved targeted therapies for Sjögren's syndrome globally.

Year-over-year improvements in gross profit, Adjusted EBITDA1 and net earnings. Closing backlog1 of $13.0 billion and reaffirmed 2026 guidance. WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) --...

SIM0505/CDH6 ADC dose optimization initiated in gynecologic cancersSIM0505 Phase 1 dose escalation study data to be presented at ASCO 2026 LNCB74 Phase 1 dose escalation trial update planned in second...

Key TakeawaysTransPerfect is serving as an official partner of the Cannes Film Festival for the second consecutive year.MPC, a TransPerfect studio, worked on several nominated titles in this year’s...

Shufti becomes the first European company to achieve iBeta Level 3, compliant across iOS & Android for single-selfie passive liveness with 0% error rate.

Lakeland Fire + Safety’s LHD Germany Completes Key Operational and Leadership Initiatives

ATLANTA, May 07, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing new medicines to treat pain and neuropathy,...

HONG KONG, May 07, 2026 (GLOBE NEWSWIRE) -- DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), a comprehensive technology enterprise engaged in the development, publishing and operating of...

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- The 10th Capital Link Maritime Leaders Summit – Greece will take place on Monday, June 1, 2026, as an in-person event at the Athenaeum Intercontinental...

CHICAGO, May 07, 2026 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the first quarter and full year 2026....